Related Experiment Video
Updated: Jun 6, 2026
09:26
Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells
Published on: February 20, 2015
Development, cell differentiation, angiogenesis--microparticles and their roles in angiogenesis
1Coagulation Unit, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Arteriosclerosis, Thrombosis, and Vascular Biology
|December 17, 2010
Summary
Microparticles (MPs), released by cells, act as messengers carrying proteins and nucleic acids. These MPs are crucial for cell communication, potentially serving as disease biomarkers and therapeutic targets.
Area of Science:
- Cell Biology
- Biochemistry
- Immunology
Background:
- Cells release microparticles (MPs), which are small membrane vesicles, during activation and apoptosis.
- MP properties and functions are cell- and pathway-dependent, influencing their molecular cargo.
- MPs play roles in immunomodulation, inflammation, coagulation, and intercellular communication.
Purpose of the Study:
- To review current knowledge on microparticle (MP) functional roles.
- To focus on MP-mediated transfer of proteins, nucleic acids, and signal transduction stimulators.
- To highlight MP roles in angiogenesis and cell development.
Main Methods:
- Literature review of existing research on microparticles.
- Analysis of MP content (lipids, proteins, nucleic acids) and their intercellular transfer.
- Examination of MP involvement in angiogenesis and cell development.
Main Results:
- MPs facilitate intercellular communication by transferring molecular signals.
- MPs mediate angiogenesis-related signals and influence cell development.
- MP investigation can reveal novel cellular pathways and pathophysiological processes.
Conclusions:
- Microparticles are key mediators of intercellular communication, transferring diverse molecular cargo.
- MPs show potential as biomarkers for disease status and as targets for novel therapies.
- Understanding MP functions offers insights into cellular processes and disease mechanisms.
Related Concept Videos
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...